Published in Parasit Vectors on July 03, 2014
Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms. Parasit Vectors (2014) 0.88
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme. PLoS Negl Trop Dis (2015) 0.83
The genome of Onchocerca volvulus, agent of river blindness. Nat Microbiol (2016) 0.83
The Onchocerciasis Vaccine for Africa--TOVA--Initiative. PLoS Negl Trop Dis (2015) 0.81
Ecological Drivers of Mansonella perstans Infection in Uganda and Patterns of Co-endemicity with Lymphatic Filariasis and Malaria. PLoS Negl Trop Dis (2016) 0.80
Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation. Infect Dis Poverty (2015) 0.80
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Malar J (2017) 0.79
The role of 'omics' in the quest to eliminate human filariasis. PLoS Negl Trop Dis (2017) 0.75
Defining the target and the effect of imatinib on the filarial c-Abl homologue. PLoS Negl Trop Dis (2017) 0.75
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet (1997) 4.98
Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis (2009) 4.05
Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet (2005) 2.62
Control of onchocerciasis. Adv Parasitol (2006) 2.34
Loiasis. Ann Trop Med Parasitol (2006) 1.93
A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol (1994) 1.80
Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ (2002) 1.77
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future. Filaria J (2003) 1.36
Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis (2010) 1.33
A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa. Filaria J (2003) 1.32
Filariasis in Africa--treatment challenges and prospects. Clin Microbiol Infect (2011) 1.30
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria J (2005) 1.12
Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies. Acta Trop (2010) 1.11
Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance. Parasit Vectors (2011) 1.10
Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo. Parasit Vectors (2012) 0.99
Filaria zoogeography in Africa: ecology, competitive exclusion, and public health relevance. Trends Parasitol (2014) 0.87
Loa loa ecology in central Africa: role of the Congo River system. PLoS Negl Trop Dis (2012) 0.86
[Vector capacities of Similium damsnosum s.l and risk for Onchocerca volvulus transmission in Inga (Democratic Republic of Congo)]. Sante (2006) 0.79
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Control of neglected tropical diseases. N Engl J Med (2007) 14.49
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med (2006) 8.63
Rescuing the bottom billion through control of neglected tropical diseases. Lancet (2009) 6.60
Socioeconomic aspects of neglected tropical diseases. Lancet (2010) 3.03
Duffy negative antigen is no longer a barrier to Plasmodium vivax--molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis (2011) 2.15
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg (2006) 1.93
A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. Am J Trop Med Hyg (2006) 1.92
The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS Negl Trop Dis (2008) 1.74
Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg (2002) 1.73
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg (2008) 1.70
Recent progress in integrated neglected tropical disease control. Trends Parasitol (2007) 1.58
Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol (2006) 1.55
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.50
Insecticidal bed nets and filariasis transmission in Papua New Guinea. N Engl J Med (2013) 1.48
Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges. Philos Trans R Soc Lond B Biol Sci (2013) 1.47
Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One (2007) 1.45
Neglected tropical diseases and the Global Fund. Lancet (2009) 1.44
Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact. Parasit Vectors (2012) 1.40
Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control. Parasit Vectors (2011) 1.37
The future of onchocerciasis control in Africa. PLoS Negl Trop Dis (2007) 1.35
Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea. Eur J Clin Pharmacol (2006) 1.30
Malaria Panel Assay versus PCR: detection of naturally infected Anopheles melas in a coastal village of Equatorial Guinea. Malar J (2004) 1.30
Polymerase chain reaction diagnosis and the changing pattern of vector ecology and malaria transmission dynamics in papua new Guinea. Am J Trop Med Hyg (2004) 1.28
Adult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policy. Parasit Vectors (2011) 1.27
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS Negl Trop Dis (2008) 1.26
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg (2008) 1.25
CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment. Br J Clin Pharmacol (2007) 1.25
Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Expert Rev Anti Infect Ther (2013) 1.25
Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity? Parasit Vectors (2013) 1.25
Impact of different strategies to control Plasmodium infection and anaemia on the island of Bioko (Equatorial Guinea). Malar J (2006) 1.22
The contribution of mass drug administration to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci (2014) 1.21
Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. J Infect Dis (2003) 1.16
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J (2004) 1.16
Integrated mapping of lymphatic filariasis and podoconiosis: lessons learnt from Ethiopia. Parasit Vectors (2014) 1.15
Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infect Immun (2002) 1.11
Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis. Parasit Vectors (2012) 1.11
Identification of a polymorphic Plasmodium vivax microsatellite marker. Am J Trop Med Hyg (2003) 1.11
The impact of integrating the elimination programme for lymphatic filariasis into primary health care in the Dominican Republic. Int J Health Plann Manage (2007) 1.11
Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance. Parasit Vectors (2011) 1.10
Tropical anemia: one of Africa's great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS Negl Trop Dis (2008) 1.09
Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone. Parasit Vectors (2012) 1.09
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea. Filaria J (2003) 1.04
The end of lymphatic filariasis? BMJ (2009) 1.04
Short communication: Negative spatial association between lymphatic filariasis and malaria in West Africa. Trop Med Int Health (2006) 1.04
Molecular xenomonitoring of lymphatic filariasis. Am J Trop Med Hyg (2007) 1.02
Genetic population structure of Anopheles gambiae in Equatorial Guinea. Malar J (2007) 1.02
Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Eur J Clin Pharmacol (2006) 1.01
A Global Fund to Fight Neglected Tropical Diseases: is the G8 Hokkaido Toyako 2008 Summit ready? PLoS Negl Trop Dis (2008) 0.99
The 'Neglected Tropical Diseases': now a brand identity; responsibilities, context and promise. Parasit Vectors (2012) 0.98
Guinea worm (Dracunculiasis) eradication: update on progress and endgame challenges. Trans R Soc Trop Med Hyg (2014) 0.98
A qPCR-based multiplex assay for the detection of Wuchereria bancrofti, Plasmodium falciparum and Plasmodium vivax DNA. Trans R Soc Trop Med Hyg (2008) 0.97
Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance. PLoS Negl Trop Dis (2013) 0.97
Screening of Trypanosoma brucei gambiense in domestic livestock and tsetse flies from an insular endemic focus (Luba, Equatorial Guinea). PLoS Negl Trop Dis (2010) 0.97
Ecological meta-analysis of density-dependent processes in the transmission of lymphatic filariasis: survival of infected vectors. J Med Entomol (2009) 0.95
The geographical distribution of lymphatic filariasis infection in Malawi. Filaria J (2007) 0.95
Soil dust aerosols and wind as predictors of seasonal meningitis incidence in Niger. Environ Health Perspect (2014) 0.94
Once a year school-based deworming with praziquantel and albendazole combination may not be adequate for control of urogenital schistosomiasis and hookworm infection in Matuga District, Kwale County, Kenya. Parasit Vectors (2014) 0.93
Oral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal (2013) 0.90
Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone. PLoS Negl Trop Dis (2013) 0.90
Geographical factors affecting bed net ownership, a tool for the elimination of Anopheles-transmitted lymphatic filariasis in hard-to-reach communities. PLoS One (2013) 0.89
Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea. Trends Parasitol (2003) 0.89
Toll-like receptor polymorphisms in malaria-endemic populations. Malar J (2009) 0.87
Neglected tropical diseases and HIV/AIDS. Lancet (2006) 0.87
Reemergence of chikungunya virus in Bo, Sierra Leone. Emerg Infect Dis (2013) 0.86
Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am J Trop Med Hyg (2003) 0.86
Loa loa ecology in central Africa: role of the Congo River system. PLoS Negl Trop Dis (2012) 0.86
Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea. PLoS Negl Trop Dis (2011) 0.86
Exploring network theory for mass drug administration. Trends Parasitol (2013) 0.85
Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi. Trop Med Int Health (2014) 0.85
Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One (2013) 0.85
Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity. Infect Immun (2003) 0.84
An alternative approach to detect Trypanosoma in Glossina (Diptera, Glossinidae) without dissection. J Infect Dev Ctries (2008) 0.84
Baseline drivers of lymphatic filariasis in Burkina Faso. Geospat Health (2013) 0.84
Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia. Infect Immun (2004) 0.84
Accuracy of an Immunochromatographic Diagnostic Test (ICT Malaria Combo Cassette Test) Compared to Microscopy among under Five-Year-Old Children when Diagnosing Malaria in Equatorial Guinea. Malar Res Treat (2010) 0.83
Basophil competence during hookworm (Necator americanus) infection. Am J Trop Med Hyg (2007) 0.83
Lymphatic filariasis in Papua New Guinea: interdisciplinary research on a national health problem. Trends Parasitol (2003) 0.82
Antibody reactivity to linear epitopes of Plasmodium falciparum cytoadherence-linked asexual gene 9 in asymptomatic children and adults from papua new Guinea. Am J Trop Med Hyg (2005) 0.82
Filling the gap 115 years after Ronald Ross: the distribution of the Anopheles coluzzii and Anopheles gambiae s.s from Freetown and Monrovia, West Africa. PLoS One (2013) 0.82
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011. Parasit Vectors (2013) 0.81
Different lineages of Chikungunya virus in Equatorial Guinea in 2002 and 2006. Am J Trop Med Hyg (2010) 0.81
Rapid diagnostics for the endgame in lymphatic filariasis elimination. Am J Trop Med Hyg (2013) 0.81
Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea. Malar J (2013) 0.81
Glossina palpalis palpalis populations from Equatorial Guinea belong to distinct allopatric clades. Parasit Vectors (2014) 0.79
Cutaneous Leishmaniasis and Conflict in Syria. Emerg Infect Dis (2016) 0.79
The other 'neglected' eradication programme: achieving the final mile for Guinea worm disease eradication? Trans R Soc Trop Med Hyg (2007) 0.78
Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history. PLoS Negl Trop Dis (2013) 0.78
Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria. PLoS One (2012) 0.77
Role of the dental surgeon in the early detection of adults with underlying HIV infection/AIDS. Med Oral Patol Oral Cir Bucal (2012) 0.76
Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection. Trans R Soc Trop Med Hyg (2016) 0.75